MX-DTPA BrE-3

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMX-DTPA BrE-3

Drug Alias NameMonoclonal antibody MX-DTPA BrE-3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionIonising radiation emittersMucin-1 inhibitors

TargetsMucin-1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

ATC CodeN/A